Failing the Public Health — Rofecoxib, Merck, and the FDA

Topol, E. J. (2004). Failing the Public Health — Rofecoxib, Merck, and the FDA. New England Journal of Medicine.

Type

Journal article

Intellectual base

Primary research

Year

2004

DOI

10.1056/nejmp048286

DOI registrant

Massachusetts Medical Society

Link

https://doi.org/10.1056/nejmp048286

Cited by

1 citation across 1 artifact.

Domain-specific

• Adverse Drug Event
  • Merck voluntarily withdrew it worldwide in September 2004

    SupportedVerified against the source

    Read by an automated reader; not a human review. How support was checked

Verification

Does it exist? Confirmed. This work's DOI resolves to a registered record, which fixes its identity. That is all it fixes.

Does it back the claim? Read against the text for 1 of 1 citation: 1 supported. Each verdict is shown under its citation below, with what in the work backs the sentence.

Support is checked per citation rather than per work — the same source can be cited soundly in one article and wrongly in another. Per-citation recording began recently, so a citation with no recorded check is a gap in the record rather than evidence it went unchecked.

See how references were verified.

Registry ID ref:331e2f1c7c8c · see in the full table